Bromide

Bromide

SCHEMBL637005

Cc1cccc[n+]1-c1ccccc1.[Br-]

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 1/20 0.33
SMN1; SMN2 Q16637 4/20 0.47
HTT P42858 3/20 0.47
MAPT P10636 2/20 0.47
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
POLB P06746 2/20 0.42
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
GFER P55789 1/20 0.38
LMNA P02545 2/20 0.33
TSHR P16473 1/20 0.33
ALOX12 P18054 1/20 0.33
BCL2 P10415 1/20 0.32
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 1/20 0.32
NR2F2 P24468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30425848 0.98 SMN1; SMN2 (0.48) SMN1; SMN2HTTMAPTNPC1RAB9A
SCHEMBL1263770 0.98 SMN1; SMN2 (0.48) SMN1; SMN2HTTMAPTNPC1RAB9A
Hydrochloric Acid SCHEMBL636847 0.98 SMN1; SMN2 (0.48) SMN1; SMN2HTTMAPTNPC1RAB9A
SCHEMBL7262939 0.80 CA12 (0.37) SMN1; SMN2HTTMAPTNPC1RAB9A
Hydrochloric Acid SCHEMBL28754080 0.71 MAPT (0.38) SMN1; SMN2HTTMAPTTSHRBCL2
Hydrochloric Acid SCHEMBL6702513 0.71 SMN1; SMN2 (0.39) SMN1; SMN2HTTMAPTRAB9APOLB
Hydrochloric Acid SCHEMBL10708206 0.71 HDAC8 (0.40) SMN1; SMN2HTTMAPTNPC1RAB9A
Bromide SCHEMBL10613331 0.71 TP53 (0.41) SMN1; SMN2HTTMAPTNPC1RAB9A
Bromide SCHEMBL11203324 0.71 HDAC8 (0.40) SMN1; SMN2HTTMAPTNPC1RAB9A
SCHEMBL25530877 0.70 CA12 (0.37) SMN1; SMN2HTTMAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1006374-B1 Process for producing a resin having a large refractive index MITSUBISHI GAS CHEMICAL CO (JP) 2009-01-07 EP claimed
WO-2024146848-A1 CURABLE MATERIALS BASED ON CYCLIC THIOETHER COMPOUNDS, AND USES THEREOF DELO INDUSTRIE KLEBSTOFFE GMBH & CO. KGAA (DE) 2024-07-11 WO disclosed
EP-2735581-B1 COMPOSITION AND POLYMER ASAHI CHEMICAL IND (JP) 2021-07-14 EP disclosed
EP-2799455-B1 Resin composition for optical member and optical member obtained from the same MITSUBISHI GAS CHEMICAL CO (JP) 2018-03-28 EP disclosed
US-9738757-B2 Composition and polymer ASAHI KASEI CHEMICALS CORPORATION (JP) 2017-08-22 US disclosed
EP-2700636-B1 PROCESS FOR PREPARING EPISULFIDE COMPOUNDS ASAHI CHEMICAL IND (JP) 2017-08-02 EP disclosed
US-9469731-B2 Epoxide and thioepoxide functional, polymerizable composition and methods of preparing optical articles therefrom PPG INDUSTRIES OHIO, INC. (US) 2016-10-18 US disclosed
US-20160222168-A1 Composition and Polymer ASAHI KASEI CHEMICALS CORPORATION (JP) 2016-08-04 US disclosed
US-20160185910-A1 Epoxide and Thioepoxide Functional, Polymerizable Composition and Methods of Preparing Optical Articles Therefrom PPG INDUSTRIES OHIO, INC. 2016-06-30 US disclosed
US-9359324-B2 Process for preparing episulfide compounds ASAHI KASEI CHEMICALS CORPORATION (JP) 2016-06-07 US disclosed
US-6534589-B1 Catalytic curing and polymerization of episulfide compound in presence of phenolic compound MITSUBISHI GAS CHEMICAL COMPANY INC. (JP) 2003-03-18 US disclosed
US-6531532-B1 Optical apparatus formed by curing sulfides, intermetallics and 1,2-bis/-epithiopropylthio/ethane to form lenses having large refractive index and optical distortion MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2003-03-11 US disclosed
US-6472495-B1 RESIN PRODUCED BY CURING THE COMPOSITION BY POLYMERIZATION HAS AN EXCELLENT IMPACT RESISTANCE AND OPTICAL PROPERTIES, AND IS SUITABLE AS AN OPTICAL MATERIAL. POLYMERS WITH SULFIDE, SELINIUM AND TELLURIUM MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2002-10-29 US disclosed
EP-1099721-A1 Composition for producing resin MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2001-05-16 EP disclosed
US-6201061-B1 CURING A RESIN FOR OPTICAL USE MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2001-03-13 US disclosed
EP-1046931-A2 Composition for optical materials MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2000-10-25 EP disclosed
US-6130307-A POLY(THIO)URETHANES MITSUBISHI GAS CHEMICAL CO., INC. (JP) 2000-10-10 US disclosed
EP-1006374-A2 Process for producing a resin having a large refractive index MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2000-06-07 EP disclosed
EP-0950905-A2 Process for producing a novel resin for optical materials having excellent color tone and transparency MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1999-10-20 EP disclosed
EP-0936233-A2 Composition for a resin MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1999-08-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160185910-A1 Epoxide and Thioepoxide Functional, Polymerizable Composition and Methods of Preparing Optical Articles Therefrom ALOX5, EPHX2, ALOX12 ACHE 510/4885SMN1; SMN2 4074/4885HTT 3751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.